跳至主要内容
临床试验/NCT00893048
NCT00893048撤回2 期

Utility of Prednisone in the Treatment of Cellulitis

Milton S. Hershey Medical Center0 个研究点开始时间: 2010年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
主要终点
Time to cellulitis resolving

研究概览

简要总结

The prevalence of cellulitis in society is very high, as much as 3% of visits to Emergency Departments are for the treatment of this disease. The treatment of cellulitis varies depending on the severity. Low severity cases are treated with pain control and antibiotics by mouth and high severity are treated with antibiotics intravenously and pain control. The investigator's hypothesis is to see if the addition of steroids, which are known to decrease inflammation, will decrease the length of the disease process. If so, it will decrease the length of stay if IV antibiotics are needed, it will decrease duration of days out of work and decrease the overall pain control required and therefore patient satisfaction.

详细描述

The incidence of cellulitis is about 24.6 cases per 1000 person-years, which is an estimate, since cellulitis is not a reportable disease. In some Emergency Departments up to 3% of visits are for cellulitis. Depending on the severity of the disease, some are treated as outpatients, and others are admitted for IV antibiotics. In some Emergency Departments cases of cellulitis are treated in an observation area for 23 hours with doses of IV antibiotics. My proposed research is to see if the addition of one dose of prednisone the treatment will decrease the inflammatory reaction enough to decrease length of stay and treatment and increase patient satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-70 years old
  • signs/symptoms of cellulitis

排除标准

  • steroid use in last 2 weeks
  • hx of adrenal insufficiency
  • suspicion for dvt or abcess
  • systemic signs of sepsis
  • ICU admission

研究组 & 干预措施

Prednisone

Experimental

Use of prednisone to decrease LOS and overall treatment time of cellulitis

干预措施: Prednisone (Drug)

Placebo

Experimental

干预措施: Placebo Oral Tablet (Drug)

结局指标

主要结局

Time to cellulitis resolving

时间窗: 48 hours after initiation of treatment

次要结局

  • Length of stay(after treatment completed)

研究者

申办方类型
Other
责任方
Sponsor

相似试验